Foster children are prescribed psychotropic medications at 6.8x the rate of other Medicaid-enrolled children, and one-third receive no treatment monitoring

Children in foster care are 6.8 times more likely to be prescribed psychotropic medication than non-foster Medicaid-enrolled peers after controlling for age, gender, and diagnosis. A 2023 study found 26.25% of children in the child welfare system had a psychotropic prescription compared to 9.06% of other Medicaid youth. Foster children average 2.9 psychotropic drug classes simultaneously versus 1.4 for non-foster peers. Nearly 100,000 children in the system receive two or more psychotropics at once, and children in foster care are significantly more likely to be prescribed psychotropic medication without any mental health or developmental disability diagnosis on record. Why it matters: A foster child exhibiting behavioral problems from placement disruption and attachment trauma is prescribed antipsychotics or mood stabilizers by a prescriber who has never met the child before and has no access to their full medical history. So the child is sedated into compliance rather than receiving therapy that addresses the root trauma. So one-third of these children receive no treatment planning or monitoring, meaning no one is tracking side effects like metabolic syndrome, weight gain, or cognitive dulling. So the child falls further behind academically because the medications impair concentration and energy. So by the time they age out at 18, they have years of psychotropic prescriptions on their medical record, potential long-term metabolic damage, and no continuity of psychiatric care. The structural root cause is that foster children change placements, caseworkers, and healthcare providers so frequently that no single clinician maintains longitudinal oversight of their psychiatric care. Each new placement may bring a new prescriber who adds medications without reviewing or tapering existing ones. States lack centralized medication tracking systems, and consent for psychotropic medication is often granted by caseworkers or judges — not by someone with a therapeutic relationship with the child. Prescribing is faster and cheaper than trauma-focused therapy, which requires specialized providers who are scarce in many areas.